Advertisement

Topics

FDA orphan status given to Krystal's rare skin disorder therapy

06:38 EDT 10 Aug 2018 | SmartBrief

Krystal Biotech's KB105, which is being developed to treat patients with transglutaminase 1-deficient autosomal recessive con -More

Original Article: FDA orphan status given to Krystal's rare skin disorder therapy

NEXT ARTICLE

More From BioPortfolio on "FDA orphan status given to Krystal's rare skin disorder therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...